SCYNEXIS, Inc. (SCYX) Discusses Transformative Asset Acquisition and Strategic Shift Toward ADPKD Therapeutics Transcript [Seeking Alpha]
SCYNEXIS, Inc. (SCYX)
Last scynexis, inc. earnings: 11/12 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.scynexis.com/investor-relations
Company Research
Source: Seeking Alpha
Company Participants David Angulo - CEO, President & Director Jeremy Duffield Rossana Ferrara Pontoriero Ivor Macleod - Chief Financial Officer Conference Call Participants Thomas Johnson Brian Kemp Dolliver - Brookline Capital Markets, LLC, Research Division Vamil Divan - Guggenheim Securities, LLC, Research Division Presentation Operator Greetings, and welcome to the SCYNEXIS 2026 Corporate Update Call. [Operator Instructions] It is now my pleasure to introduce your host, Thomas Johnson of LifeSci Advisors. Thank you. You may begin. Thomas Johnson Thank you, operator. Before we begin, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning the financial outlook for the future, leadership's expectations on our clinical results and future financial and operational performance as well as our business strategy. Because such statements are subject to risks and uncertainties, actu
Show less
Read more
Impact Snapshot
Event Time:
SCYX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SCYX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SCYX alerts
High impacting SCYNEXIS, Inc. news events
Weekly update
A roundup of the hottest topics
SCYX
News
- Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 Million [Yahoo! Finance]Yahoo! Finance
- SCYNEXIS announces $40M private placement [Seeking Alpha]Seeking Alpha
- SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Yahoo! Finance]Yahoo! Finance
- Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 MillionBusiness Wire
- SCYNEXIS Announces $40.0 Million Private Placement [TheStreet.com]TheStreet.com
SCYX
Earnings
- 11/5/25 - Beat
SCYX
Sec Filings
- 3/31/26 - Form 8-K
- 3/31/26 - Form 8-K
- 3/31/26 - Form 8-K
- SCYX's page on the SEC website